{"filing":{"accession_number":"0001437749-26-024025","cik":"0002030617","ticker":"PMI","company_name":"Picard Medical, Inc.","form":"8-K","filing_date":"2026-07-21","report_date":null,"primary_document":"pmi20260721_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/2030617/000143774926024025/pmi20260721_8k.htm"},"events":[{"id":19277,"run_id":17341,"accession_number":"0001437749-26-024025","anchor_item_number":"5.03","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.92,"summary":"Picard Medical implemented a 1-for-50 reverse stock split to support continued compliance with NYSE American continued listing standards. The reverse split was undertaken to address delisting risk and maintain the company's exchange listing.","company_name":"Picard Medical, Inc.","ticker":"PMI","filing_date":"2026-07-21","form":"8-K","submitted_at":null,"items":[{"id":18325,"accession_number":"0001437749-26-024025","item_number":"5.03","item_title":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.92,"reasoning":"The filing discloses a 1-for-50 reverse stock split implemented to \"support continued NYSE American listing compliance\" and \"continued listing standards,\" as stated in the press release. While the Item 5.03 technically covers an amendment to the Certificate of Incorporation, the material event disclosed is the company's need to execute a reverse split to maintain its exchange listing—a delisting risk mitigation action. The explicit language about \"continued listing compliance\" and \"continued listing standards\" indicates the company faced a listing threat that the reverse split was designed to address.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-22T10:05:46.035324+00:00","company_name":"","ticker":null,"filing_date":""},{"id":18326,"accession_number":"0001437749-26-024025","item_number":"8.01","item_title":"Other Events.","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.92,"reasoning":"The disclosure explicitly states the reverse stock split is \"to support continued compliance with NYSE American continued listing standards\" and \"supporting our continued listing on NYSE American.\" This is a direct response to delisting risk — the company is implementing a 1-for-50 reverse stock split to maintain its listing, which is a material governance and capital structure action driven by exchange compliance requirements.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-22T10:05:46.035324+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":18325,"accession_number":"0001437749-26-024025","item_number":"5.03","item_title":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.92,"reasoning":"The filing discloses a 1-for-50 reverse stock split implemented to \"support continued NYSE American listing compliance\" and \"continued listing standards,\" as stated in the press release. While the Item 5.03 technically covers an amendment to the Certificate of Incorporation, the material event disclosed is the company's need to execute a reverse split to maintain its exchange listing—a delisting risk mitigation action. The explicit language about \"continued listing compliance\" and \"continued listing standards\" indicates the company faced a listing threat that the reverse split was designed to address.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-22T10:05:46.035324+00:00","company_name":"Picard Medical, Inc.","ticker":"PMI","filing_date":"2026-07-21"},{"id":18326,"accession_number":"0001437749-26-024025","item_number":"8.01","item_title":"Other Events.","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.92,"reasoning":"The disclosure explicitly states the reverse stock split is \"to support continued compliance with NYSE American continued listing standards\" and \"supporting our continued listing on NYSE American.\" This is a direct response to delisting risk — the company is implementing a 1-for-50 reverse stock split to maintain its listing, which is a material governance and capital structure action driven by exchange compliance requirements.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-22T10:05:46.035324+00:00","company_name":"Picard Medical, Inc.","ticker":"PMI","filing_date":"2026-07-21"}]}